Prawo i regulacje · 10/13/2006

Technical Correction of Two Anabolic Steroid Names

The purpose of this final rule is to correct the chemical names of two anabolic steroids in the Drug Enforcement Administration's (DEA) regulations. The Anabolic Steroid Control Act of 2004 included typographical errors in the chemical names of two anabolic steroids designated as Schedule III substances. Section 1180 of the Violence Against Women and Department of Justice Reauthorization Act of 2005 corrects these typographical errors. This Final Rule amends DEA regulations to conform to the Act.

Original source language: Federal Register — Justice DepartmentOpen original release →

Technical Correction of Two Anabolic Steroid Names

Notice of Lodging of Proposed Stipulation and Order of Settlement Under the Toxic Substances Control Act

Notice of Lodging of Proposed Final Supplemental Consent Decree Under the Clean Water Act

Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Importer of Controlled Substances Application: Irvine Labs, Inc.

Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection, for Which Approval Has Expired: Title-2026 National Survey of Victim Service Providers

Craig Cohen, DPM; Decision and Order